BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 13243117)

  • 1. An investigation into the synergistic antileukemic action of amethopterin and 6-mercaptopurine in mice.
    GOLDIN A; VENDITTI JM; HUMPHREYS SR; DENNIS D; MANTEL N; GREENHOUSE SW
    J Natl Cancer Inst; 1955 Aug; 16(1):129-38. PubMed ID: 13243117
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined treatment of advanced leukemia (L1210) in mice with amethopterin and 6-mercaptopurine.
    GOLDIN A; HUMPHREYS SR; MANTEL N; VENDITTI JM
    J Natl Cancer Inst; 1956 Nov; 17(5):631-8. PubMed ID: 13377178
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effect of amethopterin and its 3',5'-dichloro derivative on purine biosynthesis in leukemic mice.
    SCHRECKER AW; MEAD JA; LYNCH MR; GOLDIN A
    Cancer Res; 1960 Jul; 20():876-86. PubMed ID: 14443540
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the toxicity and antileukemic action of 6-mercaptopurine in mice.
    GOLDIN A; VENDITTI JM; HUMPHREYS SR; DENNIS D; MANTEL N; GREENHOUSE SW
    Ann N Y Acad Sci; 1954 Dec; 60(2):251-66. PubMed ID: 14350531
    [No Abstract]   [Full Text] [Related]  

  • 5. Modification of treatment of schedules in the management of advanced mouse leukemia with amethopterin.
    GOLDIN A; HUMPHREYS SR; MANTEL N; VENDITTI JM
    J Natl Cancer Inst; 1956 Aug; 17(2):203-12. PubMed ID: 13357939
    [No Abstract]   [Full Text] [Related]  

  • 6. The association of increased dihydrofolate reductase with amethopterin resistance in mouse leukemia.
    FRIEDKIN M; CRAWFORD E; HUMPHREYS SR; GOLDIN A
    Cancer Res; 1962 Jun; 22():600-6. PubMed ID: 13895219
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of the route of administration on the relative effectiveness of 3',5'-dichloroamethopterin and amethopterin against advanced leukemia (L1210) in mice.
    VENDITTI JM; SCHRECKER AW; MEAD JA; KLINE I; GOLDIN A
    Cancer Res; 1960 Nov; 20():1451-6. PubMed ID: 13780697
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of amethopterin resistance in leukemia. I. Effects of weak folic acid antagonists on mouse leukemias.
    BURCHENAL JH; JOHNSTON SF; WARING GB
    Proc Soc Exp Biol Med; 1951 Oct; 78(1):348-51. PubMed ID: 14892015
    [No Abstract]   [Full Text] [Related]  

  • 9. Incorporation of formate-C-14 in normal and leukemic mice during extended treatment with amethopterin and 3',5'-dichloramethopterin.
    SCHRECKER AW; MEAD JA; GOLDIN A
    Cancer Res; 1962 Jan; 22():15-20. PubMed ID: 13909245
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased levels of folic acid reductase as a mechanism of resistance to amethopterin in leukemic cells.
    FISCHER GA
    Biochem Pharmacol; 1961 Jul; 7():75-7. PubMed ID: 13699838
    [No Abstract]   [Full Text] [Related]  

  • 11. Sensitivity to analogs of thiamine pyrimidine associated with resistance to amethopterin or purine antagonists.
    GUTHRIE R; LOEBECK ME; HILLMAN MJ
    Proc Soc Exp Biol Med; 1957 Apr; 94(4):792-4. PubMed ID: 13431959
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of growth of amethopterinsensitive and amethopterin-resistant pairs of lymphocytic neoplasms by dietary folic-acid deficiency in mice.
    POTTER M; BRIGGS GM
    J Natl Cancer Inst; 1962 Feb; 28():341-51. PubMed ID: 14488297
    [No Abstract]   [Full Text] [Related]  

  • 13. Amethopterin and liver purine metabolism in vivo.
    DARROW RA; SHUSTER L; GOLDIN A
    Cancer Res; 1960 Jun; 20():620-7. PubMed ID: 13814154
    [No Abstract]   [Full Text] [Related]  

  • 14. Investigation of tumor variants recovered from mice with systemic leukemia (L1210) after extensive therapy with 3',5'-dichloroamethopterin and 3'-bromo-5'-chloroamethopterin.
    HUMPHREYS SR; GOLDIN A
    J Natl Cancer Inst; 1959 Oct; 23():633-53. PubMed ID: 14405382
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of amethopterin on tumor growth and liver glutathione levels of mice bearing lymphocytic leukemias.
    LAW LW; SHACTER B
    J Natl Cancer Inst; 1956 Sep; 17(3):391-8. PubMed ID: 13367809
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemical changes in the tissues of leukemic mice. II. The effects of amethopterin.
    CERECEDO LR; BRESNICK E
    Exp Med Surg; 1961; 19():251-7. PubMed ID: 13877688
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimetabolites.
    Allegra CJ; Baram J; Chabner BA; Yeh GC; Aiba K; Curt GA
    Cancer Chemother Biol Response Modif; 1987; 9():1-22. PubMed ID: 2484324
    [No Abstract]   [Full Text] [Related]  

  • 18. TREATMENT OF "LEUKEMIC ENCEPHALOPATHY" WITH INTRATHECAL AMETHOPTERIN.
    SOSCIA JL; DIBENEDETTO R; CROCCO J; KOMNINOS ZD
    Dis Nerv Syst; 1964 May; 25():308-10. PubMed ID: 14142792
    [No Abstract]   [Full Text] [Related]  

  • 19. EFFECTS OF OTHER AGENTS ON THE BIOLOGIC RESPONSES TO VINCALEUKOBLASTINE.
    CUTTS JH
    Biochem Pharmacol; 1964 Mar; 13():421-31. PubMed ID: 14157604
    [No Abstract]   [Full Text] [Related]  

  • 20. Chromatographic studies of purine metabolism. III. Effects of A-methopterin on formate-C14 utilization in mice bearing susceptible and dependent L1210 leukemia.
    TOMISEK AJ; KELLY HJ; REID MR; SKIPPER HE
    Arch Biochem Biophys; 1958 Nov; 78(1):83-94. PubMed ID: 13595905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.